Contrast Enhancement and 68Ga-PSMA and 18F-FDG Uptake in Homogeneous HCC Lesions and in Areas Within Mosaic HCC Lesions
| CT | 68Ga-PSMA | 18F-FDG | |||||||||||
| HU | SUV | TBR-SUV | SUV | TBR-SUV | |||||||||
| Patient | Lesion | Area(s) within lesion | E or N | Lesion | TBR | Min | Max | Min | Max | Min | Max | Min | Max |
| 1 | 1 | 1 | E | 114 | 2 | 9 | 11.7 | 3.1 | 3.2 | 1.4 | 1.8 | 1 | 0.9 |
| 2 | 1 | E | 124.5 | 2.1 | 9.5 | 14.6 | 3.3 | 3.9 | 1.6 | 2.5 | 1.1 | 1.3 | |
| 3 | 1 | E | 128 | 2.2 | 5 | 8.2 | 1.7 | 2.2 | 1.6 | 2.1 | 1.1 | 1 | |
| 4 | 1 | E | 94.5 | 1.6 | 4.2 | 5.4 | 1.5 | 1.6 | 1.4 | 2.4 | 1 | 1.2 | |
| 5 | 1 | E | 89.7 | 1.5 | 7.8 | 9.5 | 2.7 | 2.6 | 1.6 | 2 | 1.1 | 1 | |
| 6 | 1 | E | 86.7 | 1.5 | 4.6 | 7.4 | 1.6 | 2 | 1.6 | 2.3 | 1.1 | 1.2 | |
| 2 | 1 | 1 | E | 188.5 | 3.3 | 21 | 30.7 | 6.4 | 7.5 | 2.7 | 4.1 | 1.6 | 1.6 |
| 2 | 1 | E | 144.5 | 2.4 | 6 | 11.1 | 1.8 | 2.7 | 2 | 3.1 | 1.2 | 1.2 | |
| 3 | 1 | 1 | E | 99 | 1.6 | 10.5 | 17.5 | 3.3 | 3.6 | 3.8 | 6.5 | 2.5 | 3 |
| 4 | 1 | 1 | E | 117 | 1.3 | 9.1 | 13 | 3.4 | 3 | 1.8 | 2.8 | 1.1 | 1.2 |
| 2 | 1 | E | 112 | 1.2 | 7.6 | 9.2 | 2.8 | 2.1 | 2.4 | 3.5 | 1.5 | 1.5 | |
| 2 | N | 84 | 0.9 | 2.9 | 6.4 | 1.1 | 1.5 | 6.4 | 9.4 | 4 | 3.9 | ||
| 3 | 1 | E | 110.8 | 1.2 | 3.7 | 6.7 | 1.4 | 1.5 | 1.2 | 2.5 | 0.8 | 1 | |
| 4 | 1 | E | 77 | 0.9 | 4 | 6.6 | 1.5 | 1.5 | 2.8 | 3.2 | 1.8 | 1.3 | |
| 2 | N | 62 | 0.7 | 3.5 | 4.2 | 1.3 | 0.9 | 3.4 | 4.5 | 2.1 | 1.9 | ||
| 5 | 1 | E | 110 | 1.2 | 9.2 | 14.7 | 3.4 | 3.3 | 1.9 | 2.5 | 1.2 | 1 | |
| 2 | E | 127.9 | 1.4 | 7.2 | 10.9 | 2.7 | 2.5 | 2 | 3 | 1.3 | 1.3 | ||
| 3 | N | 71 | 0.8 | 2.6 | 3.9 | 1 | 0.9 | 2.7 | 2.9 | 1.7 | 1.2 | ||
| 6 | 1 | E | 127 | 1.4 | 5.7 | 9.1 | 2.1 | 2.1 | 1.9 | 2.7 | 0.6 | 1.1 | |
| 5 | 1 | 1 | E | 96.4 | 1.6 | 4.7 | 6.1 | 2.6 | 2.3 | 1.6 | 4.5 | 1.2 | 1.6 |
| 2 | 1 | E | 109.8 | 1.8 | 7 | 9.6 | 3.9 | 3.5 | 1.7 | 2.7 | 1.3 | 0.9 | |
| 3 | 1 | N | 43.5 | 0.7 | 3.2 | 4.7 | 1.8 | 1.7 | 5.2 | 5.7 | 4 | 2 | |
| 6 | 1 | 1 | E | 140 | 1.6 | 25.6 | 41.2 | 3.4 | 4.4 | 1.8 | 2.7 | 1 | 0.9 |
| 2 | 1 | N | 62 | 0.5 | 3.7 | 8.3 | 0.5 | 0.9 | 5 | 7.3 | 2.9 | 2.4 | |
| 7 | 1 | 1 | E | 75 | 1.9 | 11.4 | 11.9 | 4.2 | 3.7 | 2.4 | 3.8 | 1.3 | 1.4 |
| 2 | N | 32.2 | 0.8 | 3.6 | 3.7 | 1.3 | 1.2 | 8.3 | 9 | 4.6 | 3.3 | ||
| 2 | 1 | E | 69.8 | 1.8 | 9.4 | 14.8 | 3.5 | 4.6 | 2.6 | 2.9 | 1.4 | 1.1 | |
| 3 | 1 | E | 89.6 | 2.3 | 11.3 | 13 | 4.2 | 4.1 | 2.5 | 3.2 | 1.4 | 1.2 | |
| 4 | 1 | E | 94 | 2.4 | 13.6 | 17.3 | 5 | 5.4 | 2.4 | 2.7 | 1.3 | 1 | |
| 5 | 1 | E | 73 | 1.9 | 12.7 | 15 | 4.7 | 4.7 | 2.6 | 3 | 1.4 | 1.1 | |
| 6 | 1 | E | 92 | 2.4 | 12.5 | 16.3 | 4.6 | 5.1 | 2.5 | 3.3 | 1.4 | 1.2 | |
| 2 | N | 36 | 0.9 | 3.2 | 7.2 | 1.2 | 2.3 | 3.1 | 3.9 | 1.7 | 1.4 | ||
| 7 | 1 | E | 76 | 1.9 | 10.2 | 12 | 3.8 | 3.8 | 2 | 3.7 | 1.1 | 1.4 | |
| 8 | 1 | E | 91 | 2.3 | 9.5 | 13.5 | 3.5 | 4.2 | 1.8 | 2.7 | 1 | 1 | |
| 9 | 1 | E | 115 | 2.9 | 10 | 14.3 | 3.7 | 4.5 | 2.3 | 3.2 | 1.3 | 1.2 | |
| 2 | N | 46 | 1.2 | 4.3 | 6.8 | 1.6 | 2.1 | 4 | 7.1 | 2.2 | 2.6 | ||
| 10 | 1 | E | 97 | 2.5 | 12 | 13.3 | 4.4 | 4.2 | 2.1 | 2.8 | 1.2 | 1 | |
| 2 | N | 43 | 1.1 | 4.6 | 6 | 1.7 | 1.9 | 4.2 | 6.1 | 2.3 | 2.3 | ||
| 11 | 1 | E | 96 | 2.5 | 8.2 | 15.3 | 3 | 4.8 | 2 | 3.9 | 1.1 | 1.7 | |
| 12 | 1 | E | 104 | 2.7 | 9.9 | 15.5 | 3.7 | 4.8 | 2.4 | 3.2 | 1.3 | 1.2 | |
| 13 | 1 | E | 101 | 2.6 | 9.8 | 16.3 | 3.6 | 5.1 | 2 | 2.9 | 1.1 | 1.1 | |
| 14 | 1 | E | 93 | 2.4 | 10.4 | 15.4 | 3.9 | 4.8 | 1.8 | 2.5 | 1 | 1 | |
| 15 | 1 | E | 110 | 2.8 | 9.5 | 17.3 | 3.5 | 5.4 | 2.5 | 3 | 1.4 | 1.1 | |
| 16 | 1 | E | 100 | 2.6 | 8.5 | 11.7 | 3.1 | 3.7 | 2.5 | 3.7 | 1.4 | 1.4 | |
| 2 | N | 51 | 1.3 | 3.8 | 6.7 | 1.4 | 2.1 | 3 | 4.3 | 1.7 | 1.6 | ||
| 17 | 1 | E | 101 | 2.6 | 12 | 13.5 | 4.4 | 4.2 | 2 | 3.7 | 1.1 | 1.4 | |
E = enhancing tumor areas; N = nonenhancing tumor areas; Min = minimum; Max = maximum.